Thermo Fisher plans to price fixed-rate notes in two tranches

By Devika Patel

Knoxville, Tenn., Aug. 10 – Thermo Fisher Scientific Inc. is expected to sell dollar-denominated fixed-rate senior notes in two parts, according to a 424B5 filing with the Securities and Exchange Commission.

The notes feature a make-whole call and then a par call.

Goldman Sachs & Co., BofA Merrill Lynch, Citigroup Global Markets Inc. and J.P. Morgan Securities LLC are the bookrunners.

Proceeds will be used to help fund the company’s planned $5.2 billion acquisition of Patheon NV.

Thermo Fisher is a Waltham, Mass.-based science technology company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.